Tags EPA
Tag: EPA
EPA’s rollback of the 2009 GHG Endangerment Finding reshapes climate policy, but PFAS rules remain distinct. Investors cannot confuse delay with deregulation.
BioLargo's Q3 2025 report shows tech traction in PFAS, Clyra™, and Cellinity™ — but monetization remains elusive post-Pooph® fallout.
EPA’s GHGRP rollback has no global effect as international disclosure mandates will govern U.S. multinationals’ material disclosures.
BioLargo's Q2 exposes value-chain gaps—regulatory lags, partner dependency, and no clear path from validation to revenue.
BioLargo’s growth hinges on its AEC, Clyra™, and Pooph® innovations, but delays and cash burn turn Q2–Q3 into a critical test for its long-term ambitions.
BioLargo CEO Dennis P. Calvert appointed to the U.S. Environmental Technologies Trade Advisory Committee as company celebrates 80% revenue growth in 2024.
BioLargo, Inc. starts its Lake Stockholm PFAS removal pilot this month with its efficient AEC technology, reducing hazardous waste by over 99% compared to GAC.
BioLargo's recent financials and corporate updates highlight continued growth of its AEC PFAS-removal technology soon to be operational at commercial scale.
BioLargo's recent financials and corporate updates highlight more strengths and opportunities over weaknesses and threats among its products and services, including PFAS removal.
Discover the latest on BioLargo's small-scale sodium-sulfur battery manufacturing facility in Oak Ridge, Tennessee, paving the way for greener energy storage.
